ADHD and the Turbulence of Puberty
Adolescent hormonal changes impact ADHD symptoms, behavior, and responses to treatment. Here’s how to navigate the storm.
Puberty and ADHD: Article Contents
Puberty is a hurricane of emotional, physical, behavioral, and social changes — and ADHD is the undercurrent that fuels its strength and intensity.
Already prone to impulsivity and intense emotional reactions, teens with ADHD experience higher highs and lower lows while their brains continue to develop in puberty. Hormonal changes in boys and girls, we now know, can significantly alter ADHD symptoms and responses to treatment, creating a perfect storm that demands specialized understanding and support.
The Biology of Puberty
Puberty is powered by a complex interplay of biological and environmental factors.
Major Hormonal Changes: Hormonal pathways activate the production of estrogen and progesterone in females, and testosterone in males. Aside from ensuring sexual maturation, these hormones act on the brain, organizing neural circuits to create long-lasting functional and structural changes that impact behavior.
Novelty and Thrill-Seeking: Adolescent brains also undergo synaptic pruning, the refinement of neural connections to increase brain efficiency. In other words, teen brains are primed to learn, which is part of the reason we see increased novelty and thrill-seeking, identity exploration, and boundary-pushing. Even sleep patterns change in puberty partly because the brain resists stagnation. But the quest for new experiences can also lead to poor decision-making and other challenges.
Dopamine Rush: The thrill-seeking drive of adolescents is partly tied to dopamine, the neurotransmitter that plays a key role in cognition, motivation, pleasure, and reward. Though their baseline levels of dopamine are relatively low, teens’ responses to stimuli or rewards exceed those of adults’. This combination is particularly concerning for teens with ADHD, who already struggle with impulsivity and are at greater risk for substance use disorder and other addictive, sensory-seeking behaviors.
Learning and Growing: While the adolescent brain is primed for learning, it’s only about 80 percent matured. The prefrontal cortex, which directs judgment, reasoning, impulse control, emotional regulation, and decision-making, develops more slowly in ADHD brains. This exacerbates regulation issues.
Reward Over Risk: During adolescence, the ventral striatum, involved in motor control, learning, reward processing, and some decision-making, tends to dominate. This part of the brain focuses on immediate rewards rather than future outcomes, leading teens to prioritize rewards over risks. So, while teens understand risks, they are no match for the prospect of rewards, which light up an eager brain.
Read: How ADHD Impacts Adolescents
Precocious Puberty
Children who mature earlier or later than their peers may encounter confusing social expectations as they are treated in a way that is older or younger than they are, and as they (and others) compare their bodies to peers’. In central precocious puberty, puberty strikes early and floods a still-developing, young brain with hormones before key emotional, cognitive, and other neural circuits have matured. This mismatch, whereby the body develops faster than the brain is ready for, increases the risk for depression, anxiety, and other conditions, especially in girls.1
It’s important to watch for signs of early puberty, like acne, pubic hair, and increased body odor before age 10. Breast development before age 8 and menstruation before age 10 are also signs, as is testicular enlargement in boys before age 9. Hormone-suppressing medications can temporarily delay puberty and allow a child to reach a more appropriate age so that their bodies and minds align better for pubertal changes.
How Hormonal Changes Drive Behavior
The onset of menstruation brings monthly fluctuations in estrogen levels, which influences dopamine activity. High estrogen levels increase dopamine activity, which improves cognitive function and emotional regulation. Conversely, the perimenstrual decline in estrogen results in decreased dopamine activity, lowering cognitive function and attention.
These fluctuations are significant in the context of ADHD. High-estrogen states stimulate the prefrontal cortex, enhancing control over the limbic system, or the emotional nervous system, and improving symptom control all around. In low-estrogen states, the prefrontal cortex is understimulated, which often translates to poorer regulation, impulse control, and mood, and a worsening of ADHD symptoms.2
Understimulation may also drive the brain to seek stimulation in other ways, like through big reactions and impulsivity. Lower estrogen levels also impair executive function, attention, and memory.
Hormonal fluctuations can affect ADHD symptoms to such a degree that some girls may only meet diagnostic criteria at certain points during their menstrual cycle. ADHD symptoms may also overlap with depression or anxiety, which commonly emerge in adolescence, emphasizing the need for differential diagnoses and holistic treatments.
Progesterone, secreted alongside estrogen to regulate the menstrual cycle and ovulation, protects dopamine neurons but decreases dopamine activity in the prefrontal cortex. Even if estrogen levels rise slightly post-ovulation during the luteal phase, progesterone can negate its positive effects on attention and hyperactivity symptoms.
Testosterone, the primary male sex hormone, also influences dopamine activity by increasing dopamine turnover and release in response to rewarding stimuli. Though ADHD-specific research is limited, studies show that testosterone can heighten impulsivity and risk-taking behaviors, which many boys with ADHD already struggle with.
Read: Hormonal Changes & ADHD — A Lifelong Tug-of-War
The Role of ADHD Medications
As puberty invariably influences ADHD symptoms, some teens may require treatment with medication for the first time and others may benefit from adjustments. ADHD medication use is particularly important at this stage because it reduces the risk for addiction and risky behaviors such as unsafe driving and unprotected sex.
Prepare to Adjust: For teens already taking medication, adjustments may be necessary to meet changing symptoms, physical growth, and other factors. The increased demands of school, extracurriculars, and social activities may mean longer days, requiring more medication coverage, for example.
If a teen is no longer responding adequately to methylphenidate, switching to an amphetamine may help. While both types of stimulants help recycle dopamine in the brain, amphetamines increase dopamine release, which could lead to more powerful effects.
The Role of Non-Stimulants: Not everyone responds optimally to stimulant medication. Non-stimulants like atomoxetine and alpha agonists may help. Atomoxetine reaches a steady level in the body that lasts throughout the day, providing more even symptom coverage. These medications are also often used for teens who have trouble sleeping or who have difficulty managing symptoms in the morning when their stimulant hasn’t yet activated.
Hormonal Status Matters: For some girls, a medication’s efficacy depends on their hormonal status. For example, girls respond better to stimulants right before ovulation, when estrogen and dopamine are high and progesterone is low. Estrogen may prime the brain to respond better to stimulants, particularly amphetamines. When estrogen is low, an increased dose of stimulants can improve symptoms without increased side effects.3
Compared to boys, girls report a stronger effect from short-acting methylphenidate earlier in the day, but it also wears off much sooner,4 , a phenomenon potentially explained by daily estrogen fluctuations. This suggests that girls may benefit more from long-acting stimulant formulations. Atomoxetine also appears to produce a greater effect on girls’ emotional regulation, hyperactivity, and impulsivity compared to boys.5
When adjusting the ADHD medication, dosage, or timing isn’t enough to counteract the impact of hormonal fluctuations, especially around periods, birth control medications and other interventions to help modulate the hormonal cycle may be warranted.
Supporting Teens Through Puberty
Understanding how puberty impacts mental health and behavior is key to supporting adolescents with ADHD through this time of transition. Consider doing the following:
- Keep communication open. Share this article and others at additu.de/adhd-teens to help your adolescent better understand the impact of hormones on ADHD.
- Establish expectations. Set limits and privileges to serve as much-needed guardrails to offset impulsivity and help regulate behaviors.
- Foster self-regulation. Practice delaying gratification to help teens exercise better control over stimulation-seeking behaviors.
- Validate feelings. Teens face enormous social pressures and expectations related to school, identity, body image, relationships, and more. Fluctuating hormones add to these challenges. Listening to your teen as they express their feelings and letting them know their experiences are understandable can promote calm and regulation.
Teenage Hormones and ADHD: Next Steps
Paul Mitrani, M.D., Ph.D., is the medical director and senior child and adolescent psychiatrist at Child Mind Institute.
SUPPORT ADDITUDE
Thank you for reading ADDitude. To support our mission of providing ADHD education and support, please consider subscribing. Your readership and support help make our content and outreach possible. Thank you.
View Article Sources
1 Graber J. A. (2013). Pubertal timing and the development of psychopathology in adolescence and beyond. Hormones and Behavior, 64(2), 262–269. https://doi.org/10.1016/j.yhbeh.2013.04.003
2 Peters, J. R., Schmalenberger, K. M., Eng, A. G., Stumper, A., Martel, M. M., & Eisenlohr-Moul, T. A. (2025). Dimensional affective sensitivity to hormones across the menstrual cycle (DASH-MC): A transdiagnostic framework for ovarian steroid influences on psychopathology. Molecular Psychiatry, 30(1), 251–262. https://doi.org/10.1038/s41380-024-02693-4
3 de Jong, M., Wynchank, D. S. M. R., van Andel, E., Beekman, A. T. F., & Kooij, J. J. S. (2023). Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage. Frontiers in Psychiatry, 14, 1306194. https://doi.org/10.3389/fpsyt.2023.1306194
4 Sonuga-Barke, E. J. S., Coghill, D., Markowitz, J. S., Swanson, J. M., Vandenberghe, M., & Hatch, S. J. (2007). Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry, 46(6), 701–710. https://doi.org/10.1097/chi.0b013e31804659f1
5 Kok, F. M., Groen, Y., Fuermaier, A. B. M., & Tucha, O. (2020). The female side of pharmacotherapy for ADHD-A systematic literature review. PloS One, 15(9), e0239257. https://doi.org/10.1371/journal.pone.0239257
